DK143981C - Analogifremgangsmaade til fremstilling af 2-(2-pyridyl)-3-(p-chlorphenyl)-propylaminer - Google Patents

Analogifremgangsmaade til fremstilling af 2-(2-pyridyl)-3-(p-chlorphenyl)-propylaminer

Info

Publication number
DK143981C
DK143981C DK534473A DK534473A DK143981C DK 143981 C DK143981 C DK 143981C DK 534473 A DK534473 A DK 534473A DK 534473 A DK534473 A DK 534473A DK 143981 C DK143981 C DK 143981C
Authority
DK
Denmark
Prior art keywords
propylamines
chlorphenyl
pyridyl
preparing
analogy procedure
Prior art date
Application number
DK534473A
Other languages
English (en)
Other versions
DK143981B (da
Inventor
Jr W J Welstead
Jr B T Merriman
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of DK143981B publication Critical patent/DK143981B/da
Application granted granted Critical
Publication of DK143981C publication Critical patent/DK143981C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK534473A 1972-10-02 1973-10-01 Analogifremgangsmaade til fremstilling af 2-(2-pyridyl)-3-(p-chlorphenyl)-propylaminer DK143981C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29386372 1972-10-02
US00293863A US3819641A (en) 1972-10-02 1972-10-02 2-(2-pyridyl)-omega-phenylalkylamines

Publications (2)

Publication Number Publication Date
DK143981B DK143981B (da) 1981-11-09
DK143981C true DK143981C (da) 1982-04-26

Family

ID=23130909

Family Applications (1)

Application Number Title Priority Date Filing Date
DK534473A DK143981C (da) 1972-10-02 1973-10-01 Analogifremgangsmaade til fremstilling af 2-(2-pyridyl)-3-(p-chlorphenyl)-propylaminer

Country Status (19)

Country Link
US (1) US3819641A (da)
JP (1) JPS614832B2 (da)
AT (1) AT329558B (da)
AU (1) AU6067373A (da)
BE (1) BE805529A (da)
CA (1) CA1018169A (da)
CH (1) CH583704A5 (da)
DE (1) DE2349493A1 (da)
DK (1) DK143981C (da)
FI (1) FI56966C (da)
FR (1) FR2201099B1 (da)
GB (1) GB1440777A (da)
IE (1) IE40373B1 (da)
IL (1) IL43335A0 (da)
NL (1) NL178787C (da)
NO (1) NO140186C (da)
PH (1) PH10660A (da)
SE (1) SE394431B (da)
ZA (1) ZA737710B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923988A (en) * 1972-10-02 1975-12-02 Robins Co Inc A H 2-(2-pyridyl)-{107 -phenylalkylamines
US4562258A (en) * 1982-02-04 1985-12-31 Findlay John W A 6-[3-Amino-1-(4-tolyl)prop-1E-enyl]pyridine-2-carboxylic acid derivatives having antihistaminic activity
US4584382A (en) * 1983-02-01 1986-04-22 Findlay John W A Pyridyl acrylate compound
US4621094A (en) * 1983-03-10 1986-11-04 Findlay John W A Anti-histaminic pyridyl compounds
JPH0434982Y2 (da) * 1986-11-21 1992-08-19
US5430044A (en) * 1987-02-06 1995-07-04 Fisons Corporation Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
CN108314631A (zh) * 2018-04-19 2018-07-24 中国科学院昆明植物研究所 二芳基乙烯类化合物及其药物组合物和其应用

Also Published As

Publication number Publication date
NL7313472A (da) 1974-04-04
CH583704A5 (da) 1977-01-14
FI56966C (fi) 1980-05-12
IL43335A0 (en) 1973-11-28
GB1440777A (en) 1976-06-23
ZA737710B (da) 1974-08-28
IE40373L (en) 1974-04-02
NO140186C (no) 1979-07-18
DE2349493A1 (de) 1974-04-18
US3819641A (en) 1974-06-25
DK143981B (da) 1981-11-09
FR2201099A1 (da) 1974-04-26
AU6067373A (en) 1975-03-27
AT329558B (de) 1976-05-25
FI56966B (fi) 1980-01-31
PH10660A (en) 1977-07-27
FR2201099B1 (da) 1977-01-28
JPS49132077A (da) 1974-12-18
NL178787B (nl) 1985-12-16
SE394431B (sv) 1977-06-27
BE805529A (fr) 1974-02-01
JPS614832B2 (da) 1986-02-13
NO140186B (no) 1979-04-09
ATA843073A (de) 1975-08-15
IE40373B1 (en) 1979-05-23
CA1018169A (en) 1977-09-27
NL178787C (nl) 1986-05-16

Similar Documents

Publication Publication Date Title
DK152050C (da) Analogifremgangsmaade til fremstilling af oxazolopyridiner
DK136214C (da) Fremgangsmade til fremstilling af 2-amino-1,4-dihydropyridinderivater
DK151628C (da) Analogifremgangsmaade til fremstilling af benzimidazolderivater
DK143981C (da) Analogifremgangsmaade til fremstilling af 2-(2-pyridyl)-3-(p-chlorphenyl)-propylaminer
DK138020B (da) Analogifremgangsmåde til fremstilling af pyrazolodiazepinforbindelser eller salte deraf.
DK134604B (da) Fremgangsmåde til fremstilling af indenyl-3-acetoglucuronider.
DK138230B (da) Analogifremgangsmåde til fremstilling af vincanolsalte.
DK131942C (da) Fremgangsmadetil fremstilling af delta4,16-11beta-hydroxy-3,20-diketopregnadiener
DK132233C (da) Fremgangsmade til fremstilling af antibiotikum a-2315.
DK136061C (da) Fremgangsmade til fremstilling af 2,6-diamino-dihydropyridiner
DK131575B (da) Analogifremgangsmåde til fremstilling af 2beta-hydroxy-3alfa-aminosteroider.
DK138645B (da) Analogifremgangsmåde til fremstilling af sulfamoylfenyl-imidazolidiner.
DK138745B (da) Fremgangsmåde til fremstilling af cephalexin eller salte deraf.
DK143336C (da) Analogifremgangsmaade til fremstilling af 2-quinoxalincarboxamid-1,4-dioxider
DK129657B (da) Analogifremgangsmåde til fremstilling af 3-methylpyrazol-5-carboxamider.
DK135166B (da) Analogifremgangsmåde til fremstilling af 2-methyl-5-nitro-imidazoler.
DK145462C (da) Fremgangsmaade til fremstilling af 15-alkyl-prostaglandin e-forbindelser
DK134236B (da) Analogifremgangsmåde til fremstilling af 3-cycloalkoxy-16alfa-cyanopregn-5-en-20-oner.
DK132410B (da) Analogifremgangsmåde til fremstilling af 2-amino-4H-pyraner.
NL151049B (nl) Werkwijze om cement te bereiden.
DK139225B (da) Fremgangsmåde til fremstilling af morphanthridiner.
DK134776B (da) Fremgangsmade til fremstilling af pseudowollastonit
SE411623B (sv) Forfarande for framstellning av 2-(2-aminobensoyl)pyridiner
DK138323B (da) Fremgangsmåde til fremstilling af bis-chromonylforbindelser.
DK132283B (da) Analogifremgangsmåde til fremstilling af 15-oxasteroider.